CHRDL1 and prostate adenocarcinoma: Specifically, expression of CHRDL1 was a risk factor for 7 types of cancers, including KIPAN, STAD, KIRC, COAD, COADREAD, and BLCA (HR > 1, p < 0.05), and it was a protective factor for 5 types of cancers, such as prostate adenocarcinoma (PRAD), SKCM-M, SKCM, MESO, and LUAD (HR < 1, p < 0.05) (Figure 3C).